To circumvent this dilemma, we chose an experimentally robust cervical cancer cell line (HeLa), which has a comparable expression of CREB1 to many CREB1 sensitive cancer cell lines, to generate the CREB1 KO cells. This evidence concerns the gene CREB1 and cancer.